{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T04:16:57Z","timestamp":1784175417707,"version":"3.55.0"},"reference-count":58,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,2,8]],"date-time":"2023-02-08T00:00:00Z","timestamp":1675814400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.cell.2023.01.043","type":"journal-article","created":{"date-parts":[[2023,2,23]],"date-time":"2023-02-23T10:30:37Z","timestamp":1677148237000},"page":"1013-1025.e24","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["Discovery of natural-product-derived sequanamycins as potent oral anti-tuberculosis agents"],"prefix":"10.1016","volume":"186","author":[{"given":"Jidong","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Lair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Roubert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kwame","family":"Amaning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Bel\u00e9n","family":"Barrio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yannick","family":"Benedetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhicheng","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongliang","family":"Xing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8698-0243","authenticated-orcid":false,"given":"Scott G.","family":"Franzblau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Baurin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2090-3744","authenticated-orcid":false,"given":"Florence","family":"Bordon-Pallier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cathy","family":"Cantalloube","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Sans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Silve","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Blanc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Fraisse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexey","family":"Rak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lasse B.","family":"Jenner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gulnara","family":"Yusupova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marat","family":"Yusupov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junjie","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takushi","family":"Kaneko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7392-6398","authenticated-orcid":false,"given":"T.J.","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nader","family":"Fotouhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Nuermberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandeep","family":"Tyagi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabrice","family":"Betoudji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9522-1230","authenticated-orcid":false,"given":"Anna","family":"Upton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James C.","family":"Sacchettini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Lagrange","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cell.2023.01.043_bib1","unstructured":"World Heath Organization. (2019). Global Tuberculosis Report. https:\/\/www.who.int\/publications\/i\/item\/9789241565714."},{"key":"10.1016\/j.cell.2023.01.043_bib2","unstructured":"The Working Group of New TB Drugs Global TB New Drug Pipeline. https:\/\/www.newtbdrugs.org\/pipeline\/clinical."},{"key":"10.1016\/j.cell.2023.01.043_bib3","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1056\/NEJMc1500286","article-title":"Linezolid for XDR-TB--final study outcomes","volume":"373","author":"Lee","year":"2015","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.cell.2023.01.043_bib4","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.1056\/NEJMoa1901814","article-title":"Treatment of highly drug-resistant pulmonary tuberculosis","volume":"382","author":"Conradie","year":"2020","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.cell.2023.01.043_bib5","unstructured":"National Institute of Health. Safety and Efficacy of Various Doses and Treatment Durations of Linezolid Plus Bedaquiline and Pretomanid in Participants With Pulmonary TB, XDR-TB, Pre- XDR-TB or Non-responsive\/Intolerant MDR-TB (ZeNix). https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03086486."},{"key":"10.1016\/j.cell.2023.01.043_bib6","unstructured":"National Institute of Health. Pragmatic Clinical Trial for a More Effective Concise and Less Toxic MDR-TB Treatment Regimen(S) (TB-PRACTECAL). https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02589782."},{"key":"10.1016\/j.cell.2023.01.043_bib7","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1128\/AAC.03822-14","article-title":"Contribution of the nitroimidazoles PA-824 and TBA-354 to the activity of novel regimens in murine models of tuberculosis","volume":"59","author":"Tasneen","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.cell.2023.01.043_bib8","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1128\/AAC.01691-15","article-title":"Contribution of oxazolidinones to the efficacy of novel regimens containing bedaquiline and pretomanid in a mouse model of tuberculosis","volume":"60","author":"Tasneen","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.cell.2023.01.043_bib9","doi-asserted-by":"crossref","first-page":"3114","DOI":"10.1128\/AAC.00384-12","article-title":"Sterilizing activities of novel combinations lacking first- and second-line drugs in a murine model of tuberculosis","volume":"56","author":"Williams","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.cell.2023.01.043_bib10","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1128\/AAC.00264-06","article-title":"Intrinsic macrolide resistance of the Mycobacterium tuberculosis complex is inducible","volume":"50","author":"Andini","year":"2006","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.cell.2023.01.043_bib11","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1128\/AAC.49.4.1447-1454.2005","article-title":"In\u00a0vitro and in\u00a0vivo activities of macrolide derivatives against Mycobacterium tuberculosis","volume":"49","author":"Falzari","year":"2005","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.cell.2023.01.043_bib12","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.molcel.2015.10.019","article-title":"Blast from the past: reassessing forgotten translation inhibitors, antibiotic selectivity, and resistance mechanisms to aid drug development","volume":"61","author":"Arenz","year":"2016","journal-title":"Mol. Cell"},{"key":"10.1016\/j.cell.2023.01.043_bib13","doi-asserted-by":"crossref","first-page":"17158","DOI":"10.1073\/pnas.1008685107","article-title":"Revisiting the structures of several antibiotics bound to the bacterial ribosome","volume":"107","author":"Bulkley","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.cell.2023.01.043_bib14","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/nrmicro3200","article-title":"The path of anti-tuberculosis drugs: from blood to lesions to mycobacterial cells","volume":"12","author":"Dartois","year":"2014","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.cell.2023.01.043_bib15","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1021\/jm101317f","article-title":"Modeling cellular pharmacokinetics of 14- and 15-membered macrolides with physicochemical properties","volume":"54","author":"Stepani\u0107","year":"2011","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.cell.2023.01.043_bib16","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1007\/s00249-008-0338-4","article-title":"Quantitative modeling of selective lysosomal targeting for drug design","volume":"37","author":"Trapp","year":"2008","journal-title":"Eur. Biophys. J."},{"key":"10.1016\/j.cell.2023.01.043_bib17","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.molcel.2008.02.026","article-title":"Molecular mechanism of drug-dependent ribosome stalling","volume":"30","author":"Vazquez-Laslop","year":"2008","journal-title":"Mol. Cell"},{"key":"10.1016\/j.cell.2023.01.043_bib18","doi-asserted-by":"crossref","first-page":"12200","DOI":"10.1073\/pnas.0505446102","article-title":"Ancestral antibiotic resistance in Mycobacterium tuberculosis","volume":"102","author":"Morris","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.cell.2023.01.043_bib19","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1093\/cid\/cix992","article-title":"Bedaquiline resistance: its emergence, mechanism, and prevention","volume":"66","author":"Nguyen","year":"2018","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.cell.2023.01.043_bib20","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1128\/AAC.38.4.773","article-title":"Cloning and nucleotide sequence of Mycobacterium tuberculosis gyrA and gyrB genes and detection of quinolone resistance mutations","volume":"38","author":"Takiff","year":"1994","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.cell.2023.01.043_bib21","doi-asserted-by":"crossref","first-page":"5316","DOI":"10.1128\/AAC.00308-15","article-title":"Mutations in genes for the F420 biosynthetic pathway and a nitroreductase enzyme are the primary resistance determinants in spontaneous in\u00a0vitro-selected PA-824-resistant mutants of Mycobacterium tuberculosis","volume":"59","author":"Haver","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.cell.2023.01.043_bib22","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1128\/AAC.01189-07","article-title":"In\u00a0vitro-selected linezolid-resistant Mycobacterium tuberculosis mutants","volume":"52","author":"Hillemann","year":"2008","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.cell.2023.01.043_bib23","doi-asserted-by":"crossref","first-page":"E5805","DOI":"10.1073\/pnas.1517952112","article-title":"Structural insights into species-specific features of the ribosome from the pathogen Staphylococcus aureus","volume":"112","author":"Eyal","year":"2015","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.cell.2023.01.043_bib24","doi-asserted-by":"crossref","first-page":"38942","DOI":"10.1074\/jbc.M505727200","article-title":"Methyltransferase Erm(37) slips on rRNA to confer atypical resistance in Mycobacterium tuberculosis","volume":"280","author":"Madsen","year":"2005","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.cell.2023.01.043_bib25","doi-asserted-by":"crossref","first-page":"393","DOI":"10.3109\/10409230903307311","article-title":"The A-Z of bacterial translation inhibitors","volume":"44","author":"Wilson","year":"2009","journal-title":"Crit. Rev. Biochem. Mol. Biol."},{"key":"10.1016\/j.cell.2023.01.043_bib26","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1038\/s41589-020-00715-0","article-title":"Structure of Erm-modified 70S ribosome reveals the mechanism of macrolide resistance","volume":"17","author":"Svetlov","year":"2021","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.cell.2023.01.043_bib27","doi-asserted-by":"crossref","first-page":"17152","DOI":"10.1073\/pnas.1007988107","article-title":"Structures of the Escherichia coli ribosome with antibiotics bound near the peptidyl transferase center explain spectra of drug action","volume":"107","author":"Dunkle","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.cell.2023.01.043_bib28","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/S0969-2126(03)00022-4","article-title":"Structural basis for the antibiotic activity of ketolides and azalides","volume":"11","author":"Schl\u00fcnzen","year":"2003","journal-title":"Structure"},{"key":"10.1016\/j.cell.2023.01.043_bib29","doi-asserted-by":"crossref","first-page":"4276","DOI":"10.1128\/JB.185.14.4276-4279.2003","article-title":"Structural insight into the antibiotic action of telithromycin against resistant mutants","volume":"185","author":"Berisio","year":"2003","journal-title":"J.\u00a0Bacteriol."},{"key":"10.1016\/j.cell.2023.01.043_bib30","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1093\/infdis\/jiaa016","article-title":"Pharmacodynamic correlates of linezolid activity and toxicity in murine models of tuberculosis","volume":"223","author":"Bigelow","year":"2021","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.cell.2023.01.043_bib31","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1126\/science.aaa4690","article-title":"Antibiotics. Targeting DnaN for tuberculosis therapy using novel griselimycins","volume":"348","author":"Kling","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.cell.2023.01.043_bib32","doi-asserted-by":"crossref","first-page":"4185","DOI":"10.1128\/AAC.00137-14","article-title":"Pharmacokinetic and pharmacodynamic evaluation of AZD5847 in a mouse model of tuberculosis","volume":"58","author":"Balasubramanian","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.cell.2023.01.043_bib33","doi-asserted-by":"crossref","first-page":"4178","DOI":"10.1128\/AAC.00830-09","article-title":"Paradoxical effect of isoniazid on the activity of rifampin-pyrazinamide combination in a mouse model of tuberculosis","volume":"53","author":"Almeida","year":"2009","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.cell.2023.01.043_bib34","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1164\/rccm.200310-1380OC","article-title":"Moxifloxacin-containing regimen greatly reduces time to culture conversion in murine tuberculosis","volume":"169","author":"Nuermberger","year":"2004","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.cell.2023.01.043_bib35","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1164\/rccm.200904-0611OC","article-title":"Addition of PNU-100480 to first-line drugs shortens the time needed to cure murine tuberculosis","volume":"180","author":"Williams","year":"2009","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.cell.2023.01.043_bib36","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1038\/s41467-022-28078-1","article-title":"Interplay between an ATP-binding cassette F protein and the ribosome from Mycobacterium tuberculosis","volume":"13","author":"Cui","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.cell.2023.01.043_bib37","doi-asserted-by":"crossref","first-page":"3605","DOI":"10.1021\/ja00530a048","article-title":"23672 RP, a new macrolide antibiotic from Streptomyces chryseus. Mass spectrometry study and x-ray structure determination","volume":"102","author":"Arnoux","year":"1980","journal-title":"J.\u00a0Am. Chem. Soc."},{"key":"10.1016\/j.cell.2023.01.043_bib38","doi-asserted-by":"crossref","first-page":"10884","DOI":"10.1093\/nar\/gkx785","article-title":"Structural insights into species-specific features of the ribosome from the human pathogen Mycobacterium tuberculosis","volume":"45","author":"Yang","year":"2017","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.cell.2023.01.043_bib39","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/nmeth.4169","article-title":"cryoSPARC: algorithms for rapid unsupervised cryo-EM structure determination","volume":"14","author":"Punjani","year":"2017","journal-title":"Nat. Methods"},{"key":"10.1016\/j.cell.2023.01.043_bib40","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1002\/jcc.20084","article-title":"UCSF Chimera--a visualization system for exploratory research and analysis","volume":"25","author":"Pettersen","year":"2004","journal-title":"J.\u00a0Comput. Chem."},{"key":"10.1016\/j.cell.2023.01.043_bib41","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1107\/S0907444910007493","article-title":"Features and development of coot","volume":"66","author":"Emsley","year":"2010","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"10.1016\/j.cell.2023.01.043_bib57","doi-asserted-by":"crossref","unstructured":"Afonine P.V., Poon B.K., Read R.J., Sobolev O.V., Terwilliger T.C., Urzhumtsev A., Adams P.D. Real-space refinement in PHENIX for cryo-EM and crystallography. Acta. Crystallogr. D. Struct. Biol. 74:531\u2013544.","DOI":"10.1107\/S2059798318006551"},{"key":"10.1016\/j.cell.2023.01.043_bib58","doi-asserted-by":"crossref","unstructured":"Scheres SH. RELION: implementation of a Bayesian approach to cryo-EM structure determination. J. Struct. Biol. 2012, 180519\u201330. https:\/\/doi.org\/10.1016\/j.jsb.2012.09.006.","DOI":"10.1016\/j.jsb.2012.09.006"},{"key":"10.1016\/j.cell.2023.01.043_bib42","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/nmeth.4193","article-title":"MotionCor2: anisotropic correction of beam-induced motion for improved cryo-electron microscopy","volume":"14","author":"Zheng","year":"2017","journal-title":"Nat. Methods"},{"key":"10.1016\/j.cell.2023.01.043_bib43","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jsb.2015.11.003","article-title":"Gctf: real-time CTF determination and correction","volume":"193","author":"Zhang","year":"2016","journal-title":"J.\u00a0Struct. Biol."},{"key":"10.1016\/j.cell.2023.01.043_bib44","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1038\/nsmb.1790","article-title":"Structural aspects of messenger RNA reading frame maintenance by the ribosome","volume":"17","author":"Jenner","year":"2010","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.cell.2023.01.043_bib45","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1016\/j.str.2015.11.002","article-title":"Structure of ribosomal silencing factor bound to Mycobacterium tuberculosis ribosome","volume":"23","author":"Li","year":"2015","journal-title":"Structure"},{"key":"10.1016\/j.cell.2023.01.043_bib46","first-page":"169","article-title":"Cell-free protein synthesis with prokaryotic combined transcription-translation","volume":"267","author":"Swartz","year":"2004","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.cell.2023.01.043_bib47","doi-asserted-by":"crossref","first-page":"e42166","DOI":"10.7554\/eLife.42166","article-title":"New tools for automated high-resolution cryo-EM structure determination in RELION-3","volume":"7","author":"Zivanov","year":"2018","journal-title":"eLife"},{"key":"10.1016\/j.cell.2023.01.043_bib48","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.str.2011.12.014","article-title":"Outcome of the first electron microscopy validation task force meeting","volume":"20","author":"Henderson","year":"2012","journal-title":"Structure"},{"key":"10.1016\/j.cell.2023.01.043_bib49","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/nmeth.2262","article-title":"Correcting pervasive errors in RNA crystallography through enumerative structure prediction","volume":"10","author":"Chou","year":"2013","journal-title":"Nat. Methods"},{"key":"10.1016\/j.cell.2023.01.043_bib50","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1107\/S0907444909029436","article-title":"Electronic Ligand Builder and Optimization Workbench (eLBOW): a tool for ligand coordinate and restraint generation","volume":"65","author":"Moriarty","year":"2009","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"10.1016\/j.cell.2023.01.043_bib51","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1107\/S2059798319011471","article-title":"Macromolecular structure determination using X-rays, neutrons and electrons: recent developments in Phenix","volume":"75","author":"Liebschner","year":"2019","journal-title":"Acta Crystallogr. D Struct. Biol."},{"key":"10.1016\/j.cell.2023.01.043_bib52","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1128\/AAC.41.5.1004","article-title":"Microplate alamar blue assay versus Bactec 460 system for high-throughput screening of compounds against Mycobacterium tuberculosis and Mycobacterium avium","volume":"41","author":"Collins","year":"1997","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.cell.2023.01.043_bib53","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1128\/AAC.00055-06","article-title":"Low-oxygen-recovery assay for high-throughput screening of compounds against nonreplicating Mycobacterium tuberculosis","volume":"51","author":"Cho","year":"2007","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.cell.2023.01.043_bib54","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1046\/j.1365-2958.2002.03130.x","article-title":"Integration and excision of the Mycobacterium tuberculosis prophage-like element, phiRv1","volume":"45","author":"Bibb","year":"2002","journal-title":"Mol. Microbiol."},{"key":"10.1016\/j.cell.2023.01.043_bib55","doi-asserted-by":"crossref","first-page":"3307","DOI":"10.1016\/j.bmc.2005.12.052","article-title":"Identification of 4-amino-2-cyclohexylaminoquinazolines as metabolically stable melanin-concentrating hormone receptor 1 antagonists","volume":"14","author":"Kanuma","year":"2006","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.cell.2023.01.043_bib56","doi-asserted-by":"crossref","first-page":"8860","DOI":"10.1021\/jm401278d","article-title":"Structure-activity-relationship studies around the 2-amino group and pyridine core of antimalarial 3,5-diarylaminopyridines lead to a novel series of pyrazine analogues with oral in\u00a0vivo activity","volume":"56","author":"Younis","year":"2013","journal-title":"J.\u00a0Med. Chem."}],"container-title":["Cell"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0092867423001022?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0092867423001022?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T12:05:22Z","timestamp":1758801922000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0092867423001022"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":58,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["S0092867423001022"],"URL":"https:\/\/doi.org\/10.1016\/j.cell.2023.01.043","relation":{},"ISSN":["0092-8674"],"issn-type":[{"value":"0092-8674","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Discovery of natural-product-derived sequanamycins as potent oral anti-tuberculosis agents","name":"articletitle","label":"Article Title"},{"value":"Cell","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cell.2023.01.043","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}